GP variable | Â | Odds ratio | 95% CI | p-value | Adjusted OR2(including GP characteristics) | 95% CI | p-value | Adjusted OR2(excluding GP characteristics) | 95% CI | p-value |
---|---|---|---|---|---|---|---|---|---|---|
Gender of GP | Male | 1.0 | Â | Â | 1.0 | Â | Â | Â | Â | Â |
Female | 3.1 | 2.1, 4.7 | <0.01 | 2.5 | 1.9, 3.3 | <0.01 | ||||
Location | Rural | 1.0 | Â | Â | 1.0 | Â | Â | Â | Â | Â |
Metro | 2.3 | 1.4, 3.6 | <0.01 | 3.2 | 2.4, 4.3 | <0.01 | ||||
Age Group | <30 | 1.0 | Â | Â | 1.0 | Â | Â | Â | Â | Â |
30-44 | 0.8 | 0.5, 1.2 | 0.27 | 0.7 | 0.5, 1.1 | 0.13 | ||||
45-59 | 0.6 | 0.3, 0.9 | 0.02 | 0.5 | 0.3, 0.7 | <0.01 | ||||
60+ | 0.4 | 0.1, 1.3 | 0.13 | 0.4 | 0.3, 0.7 | <0.01 | ||||
Years in general practice | <5 | 1.0 | Â | Â | Â | Â | Â | Â | Â | Â |
5-10 | 1.0 | 0.6, 1.7 | 0.91 | Â | Â | Â | ||||
10-20 | 0.9 | 0.6, 1.5 | 0.81 | Â | Â | Â | ||||
20-30 | 0.8 | 0.4, 1.5 | 0.48 | Â | Â | Â | ||||
30+ | 0.4 | 0.1, 1.3 | 0.11 | Â | Â | Â | ||||
Country of training | Australian | 1.0 | Â | Â | Â | Â | Â | Â | Â | Â |
trained | Â | Â | Â | Â | Â | Â | ||||
Overseas trained | 0.8 | 0.5, 1.2 | 0.31 | Â | Â | Â | ||||
Interest in sexual health | No | 1.0 | Â | Â | 1.0 | Â | Â | Â | Â | Â |
Yes | 1.7 | 1.0, 2.7 | 0.04 | 1.3 | 1.0, 1.7 | 0.03 | ||||
Postgraduate qualifications | No | 1.0 | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 1.2 | 0.7, 1.9 | 0.56 | Â | Â | Â | ||||
Female age groups at highest risk of infection3 | Incorrect | 1.0 | Â | Â | 1.0 | Â | Â | 1.0 | Â | Â |
Correct | 1.8 | 1.0, 3.1 | 0.05 | 1.6 | 0.7, 3.5 | 0.26 | 1.5 | 0.7, 3.5 | 0.31 | |
Male age groups at highest risk of infection4 | Incorrect | 1.0 | Â | Â | 1.0 | Â | Â | 1.0 | Â | Â |
Correct | 1.6 | 0.9, 2.9 | 0.08 | 1.4 | 0.8, 2.7 | 0.23 | 1.6 | 0.9, 2.9 | 0.10 | |
Chlamydia is usually asymptomatic in Women | Disagree | 1.0 | Â | Â | Â | Â | Â | 1.0 | Â | Â |
Agree | 1.4 | 0.9, 2.3 | 0.18 | Â | Â | Â | 1.2 | 0.7, 2.1 | 0.44 | |
Chlamydia is usually asymptomatic in Men | Disagree | 1.0 | Â | Â | 1.0 | Â | Â | 1.0 | Â | Â |
Agree | 1.6 | 1.1, 2.2 | 0.01 | 1.4 | 1.0, 1.9 | 0.03 | 1.4 | 0.9, 1.9 | 0.10 | |
Knowledge of population groups to be targeted for screening5 | 0-2 | 1.0 | Â | Â | 1.0 | Â | Â | 1.0 | Â | Â |
3-5 | 2.0 | 1.0, 4.0 | 0.05 | 1.7 | 0.8, 3.8 | 0.16 | 2.0 | 1.0, 4.2 | 0.07 | |
6+ | 3.4 | 1.7, 6.8 | <0.01 | 2.0 | 0.9, 4.4 | 0.08 | 2.9 | 1.4, 6.2 | <0.01 | |
Treatment in men and non-pregnant women6 | Incorrect | 1.0 | Â | Â | Â | Â | Â | 1.0 | Â | Â |
Correct | 1.0 | 0.4, 2.3 | 0.97 | Â | Â | Â | 1.0 | 0.5, 2.2 | 0.92 | |
Treatment in pregnant women6 | Incorrect | 1.0 | Â | Â | Â | Â | Â | 1.0 | Â | Â |
Correct | 0.7 | 0.5, 1.0 | 0.11 | Â | Â | Â | 0.6 | 0.4, 0.9 | 0.01 | |
Retest at 12 months after a negative test7 | Incorrect | 1.0 | Â | Â | 1.0 | Â | Â | 1.0 | Â | Â |
Correct | 1.8 | 0.9, 3.5 | 0.08 | 1.2 | 0.9, 1.6 | 0.32 | 1.5 | 0.9, 2.6 | 0.16 | |
Retest at 3 months after a positive test7 | Incorrect | 1.0 | Â | Â | Â | Â | Â | 1.0 | Â | Â |
Correct | 1.0 | 0.7, 1.5 | 0.97 | Â | Â | Â | 0.9 | 0.6, 1.4 | 0.73 | |
Knowledge of symptoms suggestive of PID8 | Incorrect | 1.0 | Â | Â | Â | Â | Â | 1.0 | Â | Â |
Correct | 1.3 | 0.7, 2.2 | 0.38 | Â | Â | Â | 1.3 | 0.8, 2.0 | 0.34 | |
Knowledge of PID tests that should be done9 | Incorrect | 1.0 | Â | Â | 1.0 | Â | Â | 1.0 | Â | Â |
Correct | 1.5 | 0.9, 2.3 | 0.09 | 0.9 | 0.7, 1.2 | 0.41 | 1.1 | 0.8, 1.7 | 0.51 | |
Gender of patient2 | Male | 1.0 | Â | Â | 1.0 | Â | Â | 1.0 | Â | Â |
Female | 2.3 | 1.7, 3.1 | <0.01 | 1.9 | 1.5, 2.4 | <0.01 | 2.2 | 1.7, 2.9 | <0.01 |